Balance Sheet
Cash Flow Statement
AmortizationBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Change in Cash (2024 - 2025)

Historic Change in Cash for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to $618.1 million.

  • Abivax's Change in Cash rose 144443.45% to $618.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $488.4 million, marking a year-over-year change of. This contributed to the annual value of -$115.1 million for FY2024, which is 14729.65% down from last year.
  • Abivax's Change in Cash amounted to $618.1 million in Q3 2025, which was up 144443.45% from -$48.3 million recorded in Q2 2025.
  • Abivax's Change in Cash's 5-year high stood at $618.1 million during Q3 2025, with a 5-year trough of -$48.3 million in Q2 2025.